{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,30]],"date-time":"2026-10-30T03:42:26Z","timestamp":1793331746379,"version":"4.5.0"},"reference-count":42,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2014,10,1]],"date-time":"2014-10-01T00:00:00Z","timestamp":1412121600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2014,10,1]],"date-time":"2014-10-01T00:00:00Z","timestamp":1412121600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","ejog.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Obstetrics & Gynecology and Reproductive Biology"],"published-print":{"date-parts":[[2014,10]]},"DOI":"10.1016\/j.ejogrb.2014.08.013","type":"journal-article","created":{"date-parts":[[2014,8,17]],"date-time":"2014-08-17T08:15:31Z","timestamp":1408263331000},"page":"280-283","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":41,"special_numbering":"C","title":["Potential maternal symptomatic benefit of gabapentin and review of its safety in pregnancy"],"prefix":"10.1016","volume":"181","author":[{"suffix":"Jr.","given":"Thomas","family":"Guttuso","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Majid","family":"Shaman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Loralei L.","family":"Thornburg.","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejogrb.2014.08.013_bib0005","doi-asserted-by":"crossref","first-page":"1831","DOI":"10.1001\/jama.280.21.1831","article-title":"Gabapentin for the symptomatic treatment of painful neuropathy in patients with diabetes mellitus: a randomized controlled trial","volume":"280","author":"Backonja","year":"1998","journal-title":"JAMA"},{"key":"10.1016\/j.ejogrb.2014.08.013_bib0010","doi-asserted-by":"crossref","first-page":"1573","DOI":"10.1212\/WNL.59.10.1573","article-title":"Treatment of restless legs syndrome with gabapentin: a double-blind, cross-over study","volume":"59","author":"Garcia-Borreguero","year":"2002","journal-title":"Neurology"},{"key":"10.1016\/j.ejogrb.2014.08.013_bib0015","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1111\/j.1527-3458.2004.tb00012.x","article-title":"The biology and pharmacology of calcium channel (alpha)2(delta) proteins. Pfizer satellite symposium to the 2003 Society for Neuroscience meeting. Sheraton New Orleans Hotel, New Orleans, LA November 10, 2003","volume":"10","author":"Taylor","year":"2004","journal-title":"CNS Drug Rev"},{"key":"10.1016\/j.ejogrb.2014.08.013_bib0020","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1016\/S0028-3908(01)00172-1","article-title":"Inhibition of neuronal Ca(2+) influx by gabapentin and pregabalin in the human neocortex","volume":"42","author":"Fink","year":"2002","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.ejogrb.2014.08.013_bib0025","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1038\/sj.bjp.0704439","article-title":"Gabapentin inhibits high-threshold calcium channel currents in cultured rat dorsal root ganglion neurones","volume":"135","author":"Sutton","year":"2002","journal-title":"Br J Pharmacol"},{"key":"10.1016\/j.ejogrb.2014.08.013_bib0030","doi-asserted-by":"crossref","first-page":"1065","DOI":"10.1212\/01.WNL.0000138427.83574.A6","article-title":"Restless legs syndrome and pregnancy","volume":"63","author":"Manconi","year":"2004","journal-title":"Neurology"},{"key":"10.1016\/j.ejogrb.2014.08.013_bib0035","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1159\/000322124","article-title":"Restless legs syndrome and pregnancy: follow-up of pregnant women before and after delivery","volume":"64","author":"Neau","year":"2010","journal-title":"Eur Neurol"},{"key":"10.1016\/j.ejogrb.2014.08.013_bib0040","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1097\/AOG.0b013e3181c4f8ec","article-title":"Sleep disturbances in pregnancy","volume":"115","author":"Facco","year":"2010","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.ejogrb.2014.08.013_bib0045","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1016\/j.sleep.2004.01.013","article-title":"Pregnancy as a risk factor for restless legs syndrome","volume":"5","author":"Manconi","year":"2004","journal-title":"Sleep Med"},{"key":"10.1016\/j.ejogrb.2014.08.013_bib0050","first-page":"245","article-title":"A prospective study of nausea and vomiting during pregnancy","volume":"43","author":"Gadsby","year":"1993","journal-title":"Br J Gen Pract"},{"key":"10.1016\/j.ejogrb.2014.08.013_bib0055","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1055\/s-2000-9424","article-title":"Hyperemesis gravidarum: a current review","volume":"17","author":"Eliakim","year":"2000","journal-title":"Am J Perinatol"},{"key":"10.1016\/j.ejogrb.2014.08.013_bib0060","first-page":"94","article-title":"Hospitalizations during pregnancy among managed care enrollees","volume":"100","author":"Gazmararian","year":"2002","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.ejogrb.2014.08.013_bib0065","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1016\/j.contraception.2007.08.009","article-title":"Elective pregnancy termination in a large cohort of women with hyperemesis gravidarum","volume":"76","author":"Poursharif","year":"2007","journal-title":"Contraception"},{"key":"10.1016\/j.ejogrb.2014.08.013_bib0070","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1017\/S2040174411000249","article-title":"Prenatal exposure to hyperemesis gravidarum linked to increased risk of psychological and behavioral disorders in adulthood","volume":"2","author":"Mullin","year":"2011","journal-title":"J Dev Orig Health Dis"},{"key":"10.1016\/j.ejogrb.2014.08.013_bib0075","doi-asserted-by":"crossref","first-page":"16881","DOI":"10.1073\/pnas.1009459107","article-title":"Prenatal undernutrition and cognitive function in late adulthood","volume":"107","author":"de Rooij","year":"2010","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.ejogrb.2014.08.013_bib0080","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1055\/s-2008-1040344","article-title":"Secular trends in the treatment of hyperemesis gravidarum","volume":"25","author":"Goodwin","year":"2008","journal-title":"Am J Perinatol"},{"key":"10.1016\/j.ejogrb.2014.08.013_bib0085","doi-asserted-by":"crossref","DOI":"10.1016\/j.ajog.2011.02.029","article-title":"Medication use during pregnancy, with particular focus on prescription drugs: 1976\u20132008","volume":"205","author":"Mitchell","year":"2011","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.ejogrb.2014.08.013_bib0090","doi-asserted-by":"crossref","first-page":"1544","DOI":"10.1056\/NEJMcp1003896","article-title":"Clinical practice. Nausea and vomiting in pregnancy","volume":"363","author":"Niebyl","year":"2010","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ejogrb.2014.08.013_bib0095","doi-asserted-by":"crossref","first-page":"814","DOI":"10.1056\/NEJMoa1211035","article-title":"Ondansetron in pregnancy and risk of adverse fetal outcomes","volume":"368","author":"Pasternak","year":"2013","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ejogrb.2014.08.013_bib0100","doi-asserted-by":"crossref","first-page":"2535","DOI":"10.1007\/s00221-014-3905-1","article-title":"Gabapentin's anti-nausea and anti-emetic effects: a review","volume":"232","author":"Guttuso","year":"2014","journal-title":"Exp Brain Res"},{"key":"10.1016\/j.ejogrb.2014.08.013_bib0105","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/j.earlhumdev.2009.11.003","article-title":"Gabapentin use in hyperemesis gravidarum: a pilot study","volume":"86","author":"Guttuso","year":"2010","journal-title":"Early Hum Dev"},{"key":"10.1016\/j.ejogrb.2014.08.013_bib0110","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1016\/S1525-5050(03)00110-0","article-title":"Gabapentin exposure in human pregnancy: results from the Gabapentin Pregnancy Registry","volume":"4","author":"Montouris","year":"2003","journal-title":"Epilepsy Behav"},{"key":"10.1016\/j.ejogrb.2014.08.013_bib0115","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1136\/jnnp.2005.074203","article-title":"Malformation risks of antiepileptic drugs in pregnancy: a prospective study from the UK Epilepsy and Pregnancy Register","volume":"77","author":"Morrow","year":"2006","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"10.1016\/j.ejogrb.2014.08.013_bib0120","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1017\/S1047951104004081","article-title":"Congenital cardiac malformations in Iceland from 1990 through 1999","volume":"14","author":"Stephensen","year":"2004","journal-title":"Cardiol Young"},{"key":"10.1016\/j.ejogrb.2014.08.013_bib0125","doi-asserted-by":"crossref","first-page":"1996","DOI":"10.1001\/jama.2011.624","article-title":"Newer-generation antiepileptic drugs and the risk of major birth defects","volume":"305","author":"Molgaard-Nielsen","year":"2011","journal-title":"JAMA"},{"key":"10.1016\/j.ejogrb.2014.08.013_bib0130","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1161\/CIRCULATIONAHA.106.627224","article-title":"Congenital heart disease in the general population: changing prevalence and age distribution","volume":"115","author":"Marelli","year":"2007","journal-title":"Circulation"},{"key":"10.1016\/j.ejogrb.2014.08.013_bib0135","doi-asserted-by":"crossref","first-page":"1692","DOI":"10.1212\/WNL.0b013e3182574f39","article-title":"Comparative safety of antiepileptic drugs during pregnancy","volume":"78","author":"Hernandez-Diaz","year":"2012","journal-title":"Neurology"},{"key":"10.1016\/j.ejogrb.2014.08.013_bib0140","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/0028-2243(90)90046-4","article-title":"Ultrasound screening for fetal urinary tract malformations: a prospective study in general population","volume":"36","author":"Rosendahl","year":"1990","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"key":"10.1016\/j.ejogrb.2014.08.013_bib0145","doi-asserted-by":"crossref","first-page":"1565","DOI":"10.1212\/WNL.0b013e31828f18c1","article-title":"Pregnancy outcomes following gabapentin use: results of a prospective comparative cohort study","volume":"80","author":"Fujii","year":"2013","journal-title":"Neurology"},{"key":"10.1016\/j.ejogrb.2014.08.013_bib0150","doi-asserted-by":"crossref","first-page":"1308","DOI":"10.1016\/j.fertnstert.2005.03.086","article-title":"In vitro fertilization is associated with an increase in major birth defects","volume":"84","author":"Olson","year":"2005","journal-title":"Fertil Steril"},{"key":"10.1016\/j.ejogrb.2014.08.013_bib0155","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1097\/01.AOG.0000275287.08520.4a","article-title":"Prediction and prevention of recurrent spontaneous preterm birth","volume":"110","author":"Spong","year":"2007","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.ejogrb.2014.08.013_bib0160","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1056\/NEJM199807303390506","article-title":"Prevention of premature birth","volume":"339","author":"Goldenberg","year":"1998","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ejogrb.2014.08.013_bib0165","first-page":"65","article-title":"Reporting birth defects surveillance data 1968\u20132003","volume":"79","author":"Correa","year":"2007","journal-title":"Birth Defects Res A: Clin Mol Teratol"},{"key":"10.1016\/j.ejogrb.2014.08.013_bib0170","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1056\/NEJM198901053200104","article-title":"Malformations due to presumed spontaneous mutations in newborn infants","volume":"320","author":"Nelson","year":"1989","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ejogrb.2014.08.013_bib0175","unstructured":"NAAPR. NAAPR: Winter 2009. [cited 2014 May 6]; available from: \u3008http:\/\/www2.massgeneral.org\/aed\/newsletter\/Winter2009newsletter.pdf\u3009."},{"key":"10.1016\/j.ejogrb.2014.08.013_bib0180","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1002\/bdra.23028","article-title":"Newer anticonvulsants: lamotrigine, topiramate and gabapentin","volume":"94","author":"Holmes","year":"2012","journal-title":"Birth Defects Res: A Clin Mol Teratol"},{"key":"10.1016\/j.ejogrb.2014.08.013_bib0185","doi-asserted-by":"crossref","first-page":"2185","DOI":"10.1056\/NEJMoa0907328","article-title":"Valproic acid monotherapy in pregnancy and major congenital malformations","volume":"362","author":"Jentink","year":"2010","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ejogrb.2014.08.013_bib0190","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.eplepsyres.2008.04.022","article-title":"Pregnancy outcomes in women with epilepsy: a systematic review and meta-analysis of published pregnancy registries and cohorts","volume":"81","author":"Meador","year":"2008","journal-title":"Epilepsy Res"},{"key":"10.1016\/j.ejogrb.2014.08.013_bib0195","doi-asserted-by":"crossref","first-page":"1696","DOI":"10.1001\/jama.2013.2270","article-title":"Prenatal valproate exposure and risk of autism spectrum disorders and childhood autism","volume":"309","author":"Christensen","year":"2013","journal-title":"JAMA"},{"key":"10.1016\/j.ejogrb.2014.08.013_bib0200","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1016\/j.yebeh.2013.08.001","article-title":"Fetal antiepileptic drug exposure: adaptive and emotional\/behavioral functioning at age 6 years","volume":"29","author":"Cohen","year":"2013","journal-title":"Epilepsy Behav"},{"key":"10.1016\/j.ejogrb.2014.08.013_bib0205","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1016\/S1474-4422(12)70323-X","article-title":"Fetal antiepileptic drug exposure and cognitive outcomes at age 6 years (NEAD study): a prospective observational study","volume":"12","author":"Meador","year":"2013","journal-title":"Lancet Neurol"},{"key":"10.1016\/j.ejogrb.2014.08.013_bib0210","unstructured":"Parke-Davis. Neurontin. [cited 2014 May 6]; available from: \u3008http:\/\/www.accessdata.fda.gov\/drugsatfda_docs\/label\/2009\/020235s041,020882s028,021129s027lbl.pdf\u3009."}],"container-title":["European Journal of Obstetrics & Gynecology and Reproductive Biology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0301211514004369?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0301211514004369?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,4]],"date-time":"2025-10-04T05:35:39Z","timestamp":1759556139000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0301211514004369"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,10]]},"references-count":42,"alternative-id":["S0301211514004369"],"URL":"https:\/\/doi.org\/10.1016\/j.ejogrb.2014.08.013","relation":{},"ISSN":["0301-2115"],"issn-type":[{"value":"0301-2115","type":"print"}],"subject":[],"published":{"date-parts":[[2014,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Potential maternal symptomatic benefit of gabapentin and review of its safety in pregnancy","name":"articletitle","label":"Article Title"},{"value":"European Journal of Obstetrics & Gynecology and Reproductive Biology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejogrb.2014.08.013","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2014 Elsevier Ireland Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}